56 related articles for article (PubMed ID: 21749858)
21. Analysis of putative miRNA binding sites and mRNA 3' ends as targets for siRNA-mediated gene knockdown.
Bergauer T; Krueger U; Lader E; Pilk S; Wolter I; Bielke W
Oligonucleotides; 2009 Mar; 19(1):41-52. PubMed ID: 19196098
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
[TBL] [Abstract][Full Text] [Related]
23. Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.
Diederichs S; Haber DA
Cancer Res; 2006 Jun; 66(12):6097-104. PubMed ID: 16778182
[TBL] [Abstract][Full Text] [Related]
24. Computational prediction of plant miRNA targets.
Sun YH; Lu S; Shi R; Chiang VL
Methods Mol Biol; 2011; 744():175-86. PubMed ID: 21533693
[TBL] [Abstract][Full Text] [Related]
25. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1.
Li KK; Pang JC; Ching AK; Wong CK; Kong X; Wang Y; Zhou L; Chen Z; Ng HK
Hum Pathol; 2009 Sep; 40(9):1234-43. PubMed ID: 19427019
[TBL] [Abstract][Full Text] [Related]
26. Experimental identification of microRNA targets on the 3' untranslated region of human FMR1 gene.
Yi YH; Sun XS; Qin JM; Zhao QH; Liao WP; Long YS
J Neurosci Methods; 2010 Jun; 190(1):34-8. PubMed ID: 20435064
[TBL] [Abstract][Full Text] [Related]
27. Integrative omics analysis reveals the importance and scope of translational repression in microRNA-mediated regulation.
Liu Q; Halvey PJ; Shyr Y; Slebos RJ; Liebler DC; Zhang B
Mol Cell Proteomics; 2013 Jul; 12(7):1900-11. PubMed ID: 23550052
[TBL] [Abstract][Full Text] [Related]
28. Efficient 3'-pairing renders microRNA targeting less sensitive to mRNA seed accessibility.
Kosek DM; Banijamali E; Becker W; Petzold K; Andersson ER
Nucleic Acids Res; 2023 Nov; 51(20):11162-11177. PubMed ID: 37819016
[TBL] [Abstract][Full Text] [Related]
29. siAbasic: a comprehensive database for potent siRNA-6Ø sequences without off-target effects.
Park J; Ahn SH; Cho KM; Gu D; Jang ES; Chi SW
Database (Oxford); 2018 Jan; 2018():. PubMed ID: 30321353
[TBL] [Abstract][Full Text] [Related]
30. Binding sites of miRNA on the overexpressed genes of oral cancer using 7mer-seed match.
Moustafa MAA; Nath D; Georrge JJ; Chakraborty S
Mol Cell Biochem; 2022 May; 477(5):1507-1526. PubMed ID: 35179676
[TBL] [Abstract][Full Text] [Related]
31. Turning off a few overexpressed genes in prostate cancer with microRNAs using a 7mer-seed match model.
Purkayastha A; Roy A; Bharadaj S; Bharadaj SK; Chakraborty S
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10335-10364. PubMed ID: 37273107
[TBL] [Abstract][Full Text] [Related]
32. Transcriptome-Wide Analysis of microRNA-mRNA Correlations in Tissue Identifies microRNA Targeting Determinants.
Trinidad-Barnech JM; Fort RS; Trinidad Barnech G; Garat B; Duhagon MA
Noncoding RNA; 2023 Feb; 9(1):. PubMed ID: 36827548
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs can generate thresholds in target gene expression.
Mukherji S; Ebert MS; Zheng GX; Tsang JS; Sharp PA; van Oudenaarden A
Nat Genet; 2011 Aug; 43(9):854-9. PubMed ID: 21857679
[TBL] [Abstract][Full Text] [Related]
34. A novel approach for a joint analysis of isomiR and mRNA expression data reveals features of isomiR targeting in breast cancer.
Nersisyan S; Zhiyanov A; Engibaryan N; Maltseva D; Tonevitsky A
Front Genet; 2022; 13():1070528. PubMed ID: 36531236
[TBL] [Abstract][Full Text] [Related]
35. HuMiTar: a sequence-based method for prediction of human microRNA targets.
Ruan J; Chen H; Kurgan L; Chen K; Kang C; Pu P
Algorithms Mol Biol; 2008 Dec; 3():16. PubMed ID: 19102780
[TBL] [Abstract][Full Text] [Related]
36. Specificity and functionality of microRNA inhibitors.
Robertson B; Dalby AB; Karpilow J; Khvorova A; Leake D; Vermeulen A
Silence; 2010 Apr; 1(1):10. PubMed ID: 20359337
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs function on a new level.
O'Connell RM
Blood; 2012 Apr; 119(17):3875-6. PubMed ID: 22538495
[TBL] [Abstract][Full Text] [Related]
38. Proteomics progresses in microbial physiology and clinical antimicrobial therapy.
Chen B; Zhang D; Wang X; Ma W; Deng S; Zhang P; Zhu H; Xu N; Liang S
Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):403-413. PubMed ID: 27812806
[TBL] [Abstract][Full Text] [Related]
39. Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease.
Taguchi YH; Iwadate M; Umeyama H
BMC Bioinformatics; 2015 Apr; 16():139. PubMed ID: 25925353
[TBL] [Abstract][Full Text] [Related]
40. Comparison between the repression potency of siRNA targeting the coding region and the 3'-untranslated region of mRNA.
Lai CF; Chen CY; Au LC
Biomed Res Int; 2013; 2013():637850. PubMed ID: 23841081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
